The Contrarius Global Equity Fund aims to outperform the global equity market by investing in undervalued stocks by employing a contrarian, valuation-based approach, focusing on long-term fundamentals rather than short-term market sentiment.
The experienced investment team conducts in-depth research to identify companies trading below their intrinsic value. By taking a patient, long-term approach, the Fund seeks to generate superior returns for investors.
The Contrarius Global Equity Fund aims to achieve over the long-term higher returns than the average of the world's equity markets, as represented by the MSCI World Index (including reinvested net income), without greater risk of loss.
The Fund aims to achieve its investment objective by employing Contrarius’ valuation-based, contrarian investment philosophy to invest in selected global shares. Shares are selected following detailed proprietary research. The Fund is managed with high conviction and the Fund’s holdings are expected to comprise only those selected shares assessed by Contrarius to offer the highest value from a broad universe of global shares. The Fund does not seek to replicate the benchmark, is actively managed, and its holdings may differ materially from the benchmark in order to achieve its objective.
In implementing the Fund’s investment strategy Contrarius adheres to investment guidelines, as set out in the Fund’s Product Disclosure Statement and accompanying Reference Guide.
The Fund would likely be suitable for investors seeking capital growth over the long-term (more than 5 years) and who seek exposure to an actively managed equity fund that invests in a portfolio of global equities and equity-related securities.
Significant Features and Benefits of the Fund
The following are significant features of the Fund:
Investing in the Fund offers investors a range of benefits, including:
It is believed that long-term performance is driven by the consistent application of a sound investment philosophy. The key characteristics of our investment philosophy can be summarised as follows:
Valuation based
Contrarius seeks to buy stocks that it believes are trading below their underlying intrinsic value and which are considered to be attractive relative to other available opportunities it has evaluated. The larger the discount at which a company trades to its underlying intrinsic value, the more attractive the share. Contrarius seeks to sell stocks that it believes have reached their underlying intrinsic value or which are less attractive than other opportunities it has evaluated.
While it may be possible to determine whether a share is trading either at a discount or a premium to the company’s underlying value, it is impossible to know when the market will recognise the underlying intrinsic value of a business and re-price the share accordingly. Given our investment philosophy, the timing of both purchases and sales may appear 'early'.
In the case of purchases, the stock price could and often does continue to fall due to short-term negative sentiment and outlook for the business. Provided one’s assessment of intrinsic value was however correct, short-term price declines do not typically represent a permanent loss. The same is true of sales that may be regarded as too ‘early’. Contrarius would rather sell a stock when it reaches fair value despite the short-term positive sentiment and outlook for the business. By selling at fair value, Contrarius is able to avoid the permanent loss that is likely to result from continuing to hold a stock that ultimately corrects to fair value. At the same time the sale of the stock at fair value creates the opportunity for the Fund to establish new positions in stocks that it believes are trading at a discount to fair value.
It is believed that the consistent application of this approach is essential in achieving our objective of creating long-term wealth for our clients.
Contrarian
Given the wide-ranging interpretations of ‘value investing’, our investment philosophy is probably best described as ‘contrarian’. ‘Value investing’ is often focused on finding cheap shares characterized only by low price to earnings or price to book ratios. As a result, ‘value’ investors often shun high quality shares with above average long-term growth prospects in favour of companies with below average long-term growth prospects, simply because the latter trade on low multiples and therefore appear cheap. However, in many instances the reason these shares are trading at depressed multiples is not because their prices are depressed but because their earnings have experienced a period of above average growth and are at a cyclical high.
A contrarian approach, while always considering the underlying intrinsic value of a company, is nevertheless mindful of the earnings cycle and careful to avoid companies that appear “cheap” but which carry substantial earnings and therefore price risk. Given this contrarian approach, it is expected that our selection of shares will differ materially from that of a typical performance benchmark index.
Long-term Approach
Contrarius takes a long-term approach to investing, with a typical investment horizon of four years. It is believed that the ability to outperform in the long-term is largely determined by focusing on the long-term value of a business rather than short–term news flow. In the short-term share prices tend to be driven primarily by market sentiment and the immediate earnings outlook rather than the underlying value of the business.
Fundamental Research
Our investment philosophy is valuation based with investments selected following detailed proprietary research undertaken by Contrarius. This 'bottom-up' research seeks to determine the underlying intrinsic value of the investment.
Click here to view the Fund's latest Performance details.
Past performance is not a reliable indicator of future results. Fund unit prices fluctuate and are not guaranteed. Returns may decrease or increase as a result of currency fluctuations. When making an investment in the Fund, an investor’s capital is at risk. Information on this webpage is provided for general information only and does not take into account individual investor’s objectives, financial situation, needs or circumstances. This information does not constitute personal financial advice nor a recommendation to buy, sell or hold, nor an offer to sell or a solicitation to buy or hold units in the Fund, securities mentioned in it or any other interests. Investors should consider the appropriateness of the information provided on this webpage having regard to their individual objectives, financial situation, needs or circumstances. Investors should refer to the Fund’s Product Disclosure Statement (“PDS”) and Target Market Determination (“TMD”) before making any investment decision. The PDS, daily unit prices and additional information can be obtained by contacting Contrarius Investment Advisory Pty Ltd or from www.contrarius.com. Contrarius Global Equity Fund’s TMD is available at - https://www.contrarius.com/InvestWithUs/Documentation/. A TMD is a document which is required to be made available from 5 October 2021. It describes who this financial product is likely to be appropriate for (i.e. the target market), and any conditions around how the product can be distributed to investors. It also describes the events or circumstances where the TMD for this financial product may need to be reviewed.
The Fund’s complete name is the Contrarius Global Equity Fund (Australia Registered) (“Fund”) and is a managed investment scheme registered in Australia. The Fund was registered with the Australian Securities and Investments Commission on 8 May 2018. The Australian Registered Scheme Number (“ARSN”) is 625 826 075. The inception date of the Fund is 1 July 2018. The inception date of the Retail Class is 1 July 2018. The inception date of the Investment Strategy is 1 January 2009. Equity Trustees Limited (“Equity Trustees”) (ABN 46 004 031 298), AFSL 240975, is the Responsible Entity for the Fund. Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT). Equity Trustees has appointed Contrarius Investment Management Limited (“Contrarius” or “Investment Manager”), a company incorporated in Jersey with registered number 100697, regulated by the Jersey Financial Services Commission, registration number FSB 1906, to invest and manage the assets of the Fund. Contrarius Investment Advisory Pty Limited (“Contrarius Australia” or the “Distributor”) (ABN 48 618 145 449), an Australian incorporated company with AFSL No. 506315 is the sole distributor of the Fund in Australia.
The information provided on this webpage has been prepared by Contrarius Australia in its capacity as the distributor of the Fund. It may not be complete and up to date for the purposes of investors of the Fund. Neither Contrarius Australia, Equity Trustees, nor any of their related parties, directors or employees, provide any warranty of accuracy or reliability in relation to such information, or accept any liability to any person who relies on it.
At Contrarius our objective is to create long-term wealth for our investors through superior long-term investment performance. We believe that long-term performance is driven by the consistent application of a sound investment philosophy. The key characteristics of our investment philosophy are that it is contrarian, valuation based, long-term and based on proprietary fundamental research.
Established in 2008, Contrarius is a global investment management group that has a track record of more than 15 years of successfully applying its contrarian investment philosophy on behalf of its investors. The Contrarius Group has entities with offices in Jersey (Channel Islands), Bermuda, the United Kingdom, Australia and South Africa.
Equity Trustees Limited (ABN 46 004 031 298, AFSL No. 240975) (‘EQT’) has appointed Contrarius Investment Management Limited (‘Contrarius’), a company incorporated in Jersey and licensed by the Jersey Financial Services Commission, to invest and manage the assets of Contrarius Global Equity Fund (ARSN 625 826 075) (the ‘Fund’), as set out in the Fund’s Product Disclosure Statement. EQT is the Responsible Entity for the Fund. EQT’s responsibilities and obligations as the Fund's Responsible Entity are governed by the Fund’s Constitution, the Corporations Act and general trust law. Contrarius Investment Advisory Pty Limited (ABN 48 618 145 449) (‘Contrarius Australia’), an Australian incorporated company with AFSL No. 506315, is the distributor of the Fund in Australia.
For more information about Contrarius, including our investment philosophy and people, please visit our website at: www.contrarius.com.
Click here to view the Fund's Product Disclosure Statement.
Click here to view the Fund's Target Market Determination.
Click here to view the Fund's Reference Guide
Click here to download the Fund' latest Monthly Fact Sheet by selecting Contrarius Global Equity Fund.
The Fact Sheet provides information on the Fund’s top 10 holdings, performance and risk measures, sector allocations, and geographic exposure.
Click here to download the Fund's latest Quarterly Investment Commentary by selecting Contrarius Global Equity Fund.
What do I do if I am interested in this product or would like to speak to someone about it?
Or
By selecting “Receive Info” when viewing the listing
The issuer of this product is identified at the top of this page. The PDS and target market determination for the product are available in the Documents section of this listing. Prospective investors should consider the PDS before deciding to acquire the product. This product listing was vetted by and approved by the product issuer identified above before publishing. Investment Markets (Aust) Pty Ltd AFSL 527875 (IM) is not the issuer of the product.
IMPORTANT STATEMENT ABOUT YOUR USE OF THIS SITE
Information on this site is intended for Australian users only.
This site is operated by Investment Markets (Aust) Pty Ltd. (ACN 634 057 248) (IMA, we, us and our), the holder of Australian Financial Services Licence (AFSL) no. 527875. The content is provided solely for information purposes, is not a recommendation or an offer to buy or sell a security, and is not warranted to be correct, complete or accurate. To the extent permitted by law, neither IMA, its affiliates, nor the content providers (such as the issuers of securities who appear on the site) are responsible for any investment decisions, damages or losses resulting from, or related to, the content, data and analyses or their use. The investment products on this site and any statements made about them by their issuers are not vetted, verified or researched by IMA. The presence of an investment product on this site should not be interpreted as an implied endorsement of it by IMA. Certain content provided may constitute a summary or extract of another document such as a Product Disclosure Statement. To the extent any content is general advice, it has been prepared by IMA. Any general advice has been provided without reference to your investment objectives, financial situations or needs. For more information refer to our Financial Services Guide. To obtain advice tailored to your situation, contact a financial advisor. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (or other offer document) before making any decision to invest. Past performance does not necessarily indicate an investment product’s future performance. The content is current as at date of initial publication and may not be current as at your date of viewing. For a more complete understanding of all the terms and conditions of your use of this site click here.